Darunavir
Especificaciones
206361-99-1Número CAS
606-590-1Número CE
[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamateNombre IUPAC
C27H37N3O7SFórmula química
547.7 g/molPeso molecular
Darunavir; 206361-99-1; TMC114; TMC-114; UIC-94017; Darunavirum; TMC 114; (-)-DARUNAVIR; DTXSID0046779; UIC 94017; CHEBI:367163; TMC-41629; YO603Y8113; N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide; DTXCID8026779; (3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester; {(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester; ((1S,2R)-3-((4-Amino-benzenesulfonyl)-isobutyl-amino)-1-benzyl-2-hydroxy-propyl)-carbamic acid (3R,3aS,6aR)-(hexahydro-furo(2,3-b)furan-3-yl) ester; ((3R,3aS,6aR)-2,3,3a,4,5,6a-hexahydrofuro(5,4-b)furan-3-yl) N-((2S,3R)-4-((4-aminophenyl)sulfonyl-(2-methylpropyl)amino)-3-hydroxy-1-phenylbutan-2-yl)carbamate; ((S)-3-((4-Amino-benzenesulfonyl)-isobutyl-amino)-2-hydroxy-1-((R)-phenylmethyl)-propyl)-carbamic acid (3R,3aS,6aR)-(hexahydro-furo(2,3-b)furan-3-yl) ester; (3R,3aS,6aR)-hexahydrofuro(2,3-b)furan-3-yl N-((2S,3R)-3-hydroxy-4-(N-(2-methylpropyl)(4-aminobenzene)sulfonamido)-1-phenylbutan-2-yl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)(4-aminobenzene)sulfonamido]-1-phenylbutan-2-yl]carbamate; (3R,3aS,6aR)-tetrahydro-2H-furo(2,3-b)furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-tetrahydro-2H-furo(2,3-b)furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; [(3R,3aS,6aR)-2,3,3a,4,5,6a-hexahydrofuro[5,4-b]furan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate; Ethanolate, Darunavir; RefChem:585195; (3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester; J05AE10; 114, TMC; UIC94017; Prezista; Darunavirum [INN-Latin]; Derunavir; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate; MFCD09260006; CHEMBL1323; (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE; C27H37N3O7S; (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamate; [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate; Darunavir [USAN]; NCGC00168773-01; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate; [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate; Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester; DRV; Prezista(TM); Darunavir [INN]; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate; AIDS073035; Darunavir (USAN/INN); Darunavir [USAN:INN:BAN]; Prezista Naive; Darunavir?; UNII-YO603Y8113; HSDB 7788; 2idw; 2ien; 3bvb; 3cyw; 3ekt; 3ggu; 3lzs; 3lzu; 3lzv; 3ogp; 3pwm; 3qoz; 3tkw; 3ttp; 4hla; Darunavir (DRV); (3R,3AS,6AR)-HEXAHYDROFURO(2,3-B)FURAN-3-YL ((2S,3R)-4-((4-AMINO-N-ISOBUTYLPHENYL)SULFONAMIDO)-3-HYDROXY-1-PHENYLBUTAN-2-YL)CARBAMATE; TMC41629; TMC 41629; UIC-96017; 2f8g; 2hs1; 2hs2; 3d1z; 3so9; 3t3c; 3u7s; 4ll3; DARUNAVIR [MI]; DARUNAVIR [HSDB]; DARUNAVIR [VANDF]; DARUNAVIR [MART.]; DRV & AAG; DRV & HSA; Epitope ID:231714; DARUNAVIR [WHO-DD]; DARUNAVIR [EMA EPAR]; SCHEMBL118546; BDBM8125; orb1225723; orb1305688; UIC-940T; DARUNAVIR [ORANGE BOOK]; Darunavir, >=98% (HPLC); GTPL11243; 2f80; 2f81; 3d20; 3s53; 3s54; CJBJHOAVZSMMDJ-HEXNFIEUSA-N; GLXC-05003; HMS3715I13; EX-A4009; IVB37837; Tox21_112634; US10806794, Compound Darunavir; Darunavir & alpha1-acid glycoprotein; EBC-27304; MSK169308; s5250; AKOS015966592; CCG-269991; CS-0749; DB01264; FH20801; KS-1469; NCGC00388284-07; NCGC00388284-08; NCGC00388284-10; NCGC00388284-12; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate; AC-26778; HY-17040; CAS-206361-99-1; NS00000472; D03656; AB01565837_02; D022705; EN300-20600172; F547231; Q3765251; BRD-K84986517-001-01-8; Z2301684748; ((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-carbamic acid (3R,3aS,6aR)-hexahydrofurano(2,3-b)furan-3-yl ester; ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-CARBAMIC ACID (3R,3AS,6AR)-HEXAHYDROFURO(2,3-B)FURAN-3-YL ESTER; (3R,3AS,6AR)-HEXAHYDROFURO(2,3-B)FURAN-3-YL ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(ISOBUTYL)AMINO)-1-BENZYL-2-HYDROXYPROPYL)CARBAMATE; (3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(sup 1)-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-4-[4-amino-N-(2-methylpropyl)benzene-1-sulfonamido]-3-hydroxy-1-phenylbutan-2-yl}carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)-4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate; Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3R,3aS,6aR)-hexahydrofurano(2,3-b)furan-3-yl ester; Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl esterSinónimos
Productos que contienen Darunavir
PREZISTA 75 mg COMPRIMIDOS RECUBIERTOS CON PELICULAPREZISTA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULADARUNAVIR VIVANTA 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR VIVANTA 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULAS EFGDARUNAVIR TARBIS 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR TARBIS 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR TARBIS 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR MYLAN 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR MYLAN 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR KRKA 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR KRKA 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Página 1 de 4
Empresas que venden Darunavir
HR
Hangzhou Royall Import & Export Co.,LtdChinaSI
Sinoway Industrial Co.Ltd.ChinaAI
A.H.A International Co., Ltd.SF
Sandoz Farmaceutica S.A.SpainSA
SANDOZFrancePágina 1 de 3